GODAVARI DRUGS LTD. Share Price

GODAVARI DRUGS LTD. Share Price

BSE: 530317
|
Pharmaceuticals
|
S Cap
₹ 112.00
+₹3.10 (2.85%)
1D
Last updated 16 Sep, 2026, 15:29 IST

GODAVARI DRUGS LTD. Share Price Today

As of 16 Sep 2026, GODAVARI DRUGS LTD. share price is ₹112.00. The stock opened at ₹107.00, compared to its previous close of ₹108.90. During today's trading session, GODAVARI DRUGS LTD. share price moved in the range of ₹107.00 to ₹112.10, with an average price of ₹109.55 for the day. Looking at its last 52-week, the stock has touched a low of ₹69.70 and a high of ₹135.25.

₹107.00
2.85% up today
₹112.10
1D LOW
1D HIGH

GODAVARI DRUGS LTD. Returns Calculator

Circuit
L
H
₹87.12
₹130.68
52-week
L
H
₹69.70
₹135.25

About GODAVARI DRUGS LTD.

GODAVARI DRUGS LTD. Share Price
ISIN
INE362C01012
Sector Market Cap
₹ 129.92 Cr

Godavari Drugs Limited is an India-based company, which is engaged in the business of manufacturing of active pharmaceutical ingredients (API) and its intermediates. The Company is engaged in the business of contract manufacturing, loan license manufacturing, manufacturing and supply of API, drug intermediaries and fine chemicals. It operates through manufacture and sale of API and its intermediates segment. Its manufacturing facilities are located at the Maharashtra Industrial Development Corporation estate at Nanded, Maharashtra, India. The Company's facility has multiple production blocks for API's, drug intermediates and fine chemicals.

GODAVARI DRUGS LTD. Financial Highlights

  • Revenue: GODAVARI DRUGS LTD. reported revenue of ₹106.62 crore in FY26 vs ₹114.33 crore in FY25. It showed a decrease of 6.74% on a yearly basis.
  • Operating Profit: GODAVARI DRUGS LTD. reported an operating profit of ₹5.06 crore in FY26 vs ₹5.63 crore in FY25. It showed a decrease of 10.12% on a year-on-year basis.
  • Net Profit: GODAVARI DRUGS LTD. reported a net profit of ₹4.09 crore in FY26 vs ₹4.38 crore in FY25. It showed a decrease of 6.62% on a yearly basis.

GODAVARI DRUGS LTD. Quarterly Result Highlights

  • GODAVARI DRUGS LTD. reported revenue of ₹28.11 crore in Jun 2026, compared with ₹33.30 crore in Mar 2026, representing a decrease of 15.59% on a quarter-on-quarter (QoQ) basis.
  • GODAVARI DRUGS LTD. reported an operating profit of ₹1.18 crore in Jun 2026, compared with ₹1.62 crore in Mar 2026, representing a decrease of 27.16% on a quarter-on-quarter (QoQ) basis.
  • GODAVARI DRUGS LTD. reported a profit of ₹1.11 crore in Jun 2026, compared with ₹1.29 crore in Mar 2026, reflecting a decrease of 13.95% on a QoQ basis.
  • The earnings per share (EPS) of GODAVARI DRUGS LTD. stood at ₹5.43 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
40.23%
FII
0.00%
Other DII
1.48%
Retail and other
57.03%
Mutual funds
1.26%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
118.85
P/E
28.58
P/B
1.53
ROE
5.39%
D/E
1.01
ROCE
5.94%
Div. Yield
0.00%
EPS(TTM)
5.43
Turnover
0.55
EV/EBITDA
17.56
Net Margin
3.87%
Op. Margin
10.85%
ROA
2.08%
Quick Ratio
0.77
Curr. Ratio
2.44
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Godavari Drugs outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Godavari Drugs appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,40,278.0036.345.2713.74%0.6117.33%93.240.87%0.4810.90
Divis Laboratories2,43,966.0083.4114.5615.32%0.0019.56%629.490.33%0.5598.19
Torrent Pharmaceuticals1,84,478.0085.5721.9425.49%1.6913.85%222.760.70%0.4958.70
Zydus Lifesciences1,09,626.0023.874.0418.59%0.3117.35%237.300.09%0.3335.38
Cipla1,09,950.0032.763.1911.27%0.0014.95%423.360.96%0.4543.52
Laurus Labs1,03,902.0095.2919.6016.77%0.4016.14%97.200.10%0.6713.72
Dr. Reddy's Laboratories95,967.4030.152.5211.07%0.1812.54%377.950.70%0.4138.68
Aurobindo Pharma95,794.7025.822.539.25%0.1911.76%394.820.24%0.3841.58
Lupin93,984.1016.934.1923.76%0.0424.88%659.000.88%0.57129.18
Mankind Pharma94,531.6045.725.8011.74%0.3413.13%396.980.04%0.4449.37

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

GODAVARI DRUGS LTD. Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹105.81₹113.35₹156.71₹159.62
Other Income₹0.81₹0.98₹0.62₹0.66
Total Revenue₹106.61₹114.33₹157.33₹160.28
Total Expenses₹101.91₹108.70₹150.32₹155.57
Profit Before Tax₹5.06₹5.63₹6.92₹4.93
Tax₹0.97₹1.25₹1.37₹1.15
Profit After Tax₹4.09₹4.38₹5.55₹3.79
EPS - Basic₹5.43₹5.82₹7.37₹5.03
EPS - Diluted₹5.36₹5.82₹7.37₹5.03

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹11.47₹12.81₹13.83₹10.81
Income before WC changes₹10.67₹11.83₹13.21₹10.15
Change in Assets-₹20.90₹9.47-₹1.94-₹11.86
Change in Liabilities₹12.15-₹8.94₹8.15₹16.08
Change in WC-₹8.75₹0.52₹6.22₹4.22
Cash flow from Operations₹0.73₹11.20₹18.41₹13.22
Cash flow from Investing-₹25.95-₹19.51-₹13.22-₹8.64
Cash flow from Financing₹37.35₹8.07-₹5.65-₹3.77
Total Cash Flow₹12.14-₹0.25-₹0.46₹0.81
Cash (Start of the year)₹2.37₹2.62₹3.08₹2.28
Cash (End of the year)₹14.51₹2.37₹2.62₹3.08

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹88.63₹64.31₹46.27₹34.43
Current Assets₹111.80₹78.76₹88.48₹87.01
Total Assets₹200.43₹143.08₹134.75₹121.43
Current Liabilities₹85.14₹73.09₹82.00₹73.71
Net Current Asset₹26.65₹5.67₹6.48₹13.30
Non-Current Liabilities₹39.49₹26.64₹13.79₹14.31
Equity Capital₹75.80₹43.35₹38.97₹33.42
Total Equity & Liabilities₹200.43₹143.08₹134.75₹121.43
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
1
Neutral
6
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
51.49
Neutral
ATR (14)
7.78
Neutral
STOCH(9,6)
49.69
Neutral
STOCH RSI (14)
49.04
Neutral
ADX(9)
30.15
Bearish
UO(9)
53.82
Neutral
ROC(12)
11.12
Bullish
WillR(14)
-50.31
Neutral
Period
Simple value
Exponential vaue
5D
115.62
113.53
10D
109.02
110.7
20D
104.43
107.82
50D
109.2
108.87
100D
116.52
109.59
Volume trend — traded volume by day
16 Sep0L
15 Sep0L
11 Sep0L
10 Sep0L
9 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
GODAVARI DRUGS LTD. Share Price
GODAVARI DRUGS LTD.
Pharmaceuticals
Add Stock
Add Another

GODAVARI DRUGS LTD. Share Price FAQs

GODAVARI DRUGS LTD. share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837